about
Microbial aetiology, outcomes, and costs of hospitalisation for community-acquired pneumonia; an observational analysis.Direct haemodynamic effects of pulmonary arteriovenous malformation embolisationStatins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trialsPharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia.Increased arterial stiffness in young adults with end-stage renal disease since childhood.Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study.Cardiac oxygen supply is compromised during the night in hypertensive patientsDexamethasone treatment has no effect on the formation of pneumococcal antibodies during community-acquired pneumonia.A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice.Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumoniaComparative Survival among Older Adults with Advanced Kidney Disease Managed Conservatively Versus with Dialysis.Influence of body mass index on the association of weight changes with mortality in hemodialysis patientsMannose-binding lectin and l-ficolin polymorphisms in patients with community-acquired pneumonia caused by intracellular pathogens.Treatment with anti-inflammatory drugs in community-acquired pneumonia.Pneumococcal conjugate vaccination response in patients after community-acquired pneumonia, differences in patients with S. pneumoniae versus other pathogens.Accuracy of Cuff-Measured Blood Pressure: Systematic Reviews and Meta-Analyses.Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands.Randomized clinical trial of extended versus single-dose perioperative antibiotic prophylaxis for acute calculous cholecystitis.Sodium Restriction in Patients With CKD: A Randomized Controlled Trial of Self-management Support.Age- and gender-adjusted eGFR to estimate baseline creatinine for RIFLE criteriaAn undetected common renal arterial trunk: surgical consequences and morbidity analysis.Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy.Perceived Barriers and Support Strategies for Reducing Sodium Intake in Patients with Chronic Kidney Disease: a Qualitative Study.Bridging cardiovascular physics, physiology, and clinical practice: Karel H. Wesseling, pioneer of continuous noninvasive hemodynamic monitoring.Acute effects of peritoneal dialysis on hemodynamics.Contribution of volume overload and angiotensin II to the increased pulse wave velocity of hemodialysis patients.COSMOS: the dialysis scenario of CKD-MBD in Europe.Gestational age and birth weight in relation to aortic stiffness in healthy young adults: two separate mechanisms?Pulse pressure amplification and risk of cardiovascular disease.Determinants of augmentation index in young men: the ARYA study.Is the inverse relation between blood pressure and mortality normalized in 'low-risk' dialysis patients?Noninvasive arterial measurements of vascular damage in healthy young adults: relation to coronary heart disease risk.High-sensitivity cardiac troponin T predicts mortality after hospitalization for community-acquired pneumonia.Validation of brachial artery pressure reconstruction from finger arterial pressure.Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis.Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis.Inclusion of sepsis and hypoxaemia in mortality prediction of hospitalized patients with community-acquired pneumonia - Reply.The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients.Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients.YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia.
P50
Q33831860-748025FD-DAA3-4FEE-96CC-1D5D3BE8DCB2Q33906054-DAE58D7B-08AB-4227-977D-D822EC8F0F99Q34086279-DFEE733C-2C16-430C-92DD-D812A7D06473Q34209524-AD2CC05D-FE0D-4B1F-91EF-ED6C55F4024FQ35005448-DF3F1F27-FB9D-4DF7-BF14-8BD929F1098BQ35083604-F2C3BEEF-6584-4DB8-B0E4-3329D2FA514AQ35171388-EED7D9B8-E50A-4874-A7D0-F0D79969D37EQ35940750-CA232AF2-7B5E-4320-B56B-AFC5449942E7Q35973982-415ABBF9-6A2A-499B-B2BE-CCCD0CC9C2E3Q36191631-B897DC04-356B-46AD-86C8-D88E5B985616Q36770870-7F71CB83-4E47-486D-A6C1-9BDFD93F3C04Q37212390-F7CD9B9A-73F8-4E90-8C63-862FEB3867B3Q37835225-7081455D-9FE6-41F5-A827-05C2A5D8892CQ38009864-C85B33C5-B9CF-4F87-96D2-05155A4B3167Q38372299-3408B227-C6AB-46A8-934D-2714D1CA9154Q38657037-E9074F06-2521-4F59-9BDE-75A57AC9472DQ38698467-6B04CAB6-AFD8-4994-84A0-8472C6DCFFE4Q39000395-2AC38FD4-5133-418B-8813-41A7F0B66F82Q39087586-3D53C298-43B3-418A-8848-794C1BC8AC79Q40340245-4D588BEE-A592-47A4-A5D6-7ED4A38EE412Q40798278-C8DB85C8-204D-4E28-AABC-8DC4B7AD5F31Q42617236-B2752298-6E18-43EB-8EC3-C0C63AF856C6Q42687292-ADF8D123-51FE-44FD-82B6-6ABC7DB49D4DQ43125671-609C0E55-E48D-4530-8478-CC1827E7BF75Q43593381-C31DC97D-D2E5-4000-B139-59A48441C268Q43829996-DD660FAE-A424-41CD-8371-FF627194AFF1Q43939289-E17CA7B8-1AAE-4E14-B684-0C00BB2F3DDDQ44271995-77531A72-E0B3-4EA1-9DB6-CC116D65DAD6Q44661505-6B888008-DEF4-4B0D-9BCF-5768A7AB250EQ45192332-BFA99DB7-6514-45FF-9F51-7CC16B26A7F0Q45339570-66E86ECD-FDB0-4E8F-ACC4-5105785BD750Q46818127-8D08FA7C-093E-475E-8121-981397BD8430Q47327700-3460D43B-D182-48D8-AB2D-473498B09CB7Q47637955-6AB1D93C-663C-4949-BF15-7F62EE8FDD92Q47742675-07556E6B-9103-4FB4-9105-B59BC6DA68E3Q48259566-C5F1770E-9CB7-4AB9-BB06-92986F6312A6Q48348472-EC595242-69BF-4D80-8E57-8F27651EC9ECQ48469380-FA7C3AB9-45BC-40BC-BDC9-A9BC209EBCBFQ51152832-BA4A8B51-2D90-4F0D-844B-DC88133CCA51Q51362710-05C01357-240D-4F19-9606-4FCAB3D9B939
P50
description
researcher ORCID ID = 0000-0002-5062-2567
@en
wetenschapper
@nl
name
Willem Jan W Bos
@ast
Willem Jan W Bos
@en
Willem Jan W Bos
@nl
type
label
Willem Jan W Bos
@ast
Willem Jan W Bos
@en
Willem Jan W Bos
@nl
prefLabel
Willem Jan W Bos
@ast
Willem Jan W Bos
@en
Willem Jan W Bos
@nl
P21
P31
P496
0000-0002-5062-2567